Basic Search
|
Geographic Searches
|
Advanced Search |
Megadeals
Subsidy Tracker Parent Company Summary
Parent Company Name: Pfizer
Ownership Structure: publicly traded (ticker symbol PFE)
Headquartered in: New York
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Subsidy Summary | Subsidy Value | Number of Awards |
State/Local | $332,313,011 | 206 |
Federal (grants and allocated tax credits) | $0 | 0 |
TOTAL | $332,313,011 | 206 |
Loan / Bailout Summary | Total Face Value | Number of Awards |
State/Local loans, bond financing and venture capital | $220,000,000 | 1 |
Federal loans, loan guarantees and bailout assistance (not including repayments) | $3,542,000 | 1 |
TOTAL | $223,542,000 | 2 |
Time Period for State and Local Awards: Earliest year of data: 1975. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2008.
Time Period for Federal Awards: FY2000 to the present
Notes: Dollar totals do not include awards for which no subsidy value is disclosed.
Links: For a summary of this company's regulatory violations see its Violation Tracker summary page
here.
For an overview of this company's accountability track record, read its Corporate Rap Sheet
here.
Top 5 States for state/local awards | Total Subsidy $ | Number of Awards |
Michigan | $85,200,000 | 2 |
Connecticut | $65,000,000 | 2 |
North Carolina | $55,175,873 | 86 |
New York | $44,472,079 | 26 |
New Jersey | $38,807,831 | 5 |
All other | $43,657,228 | 85 |
Individual Subsidy Records:
Click on the company name for more information on each subsidy award.
Warning: Attempt to read property "post_title" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2057
Warning: Attempt to read property "post_name" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2059
Company | Location | Subsidy Source | Year | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
Embrex, Inc. | North Carolina | state | 2005 | $30,772 | | grant |
PFIZER INC | Tennessee | local | 2012 | $30,865 | | property tax abatement |
Hospira Inc. | Colorado | state | 2014 | $31,104 | | training reimbursement |
Embrex, Inc. | North Carolina | state | 2013 | $31,549 | | tax credit/rebate |
Embrex, Inc. | North Carolina | state | 2012 | $32,718 | | tax credit/rebate |
Pfizer Inc. | Maryland | state | 2004 | $33,734 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2008 | $33,750 | | tax credit/rebate |
Pfizer Inc & Subsidiaries | Maryland | state | 2019 | $42,853 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Maryland | state | 2020 | $48,205 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Maryland | state | 2011 | $49,888 | | tax credit/rebate |
Pfizer, Inc. | North Carolina | state | 2022 | $53,699 | | tax credit/rebate |
Icagen, Inc. | North Carolina | state | 2012 | $54,345 | | tax credit/rebate |
Pfizer, Inc. | Maryland | state | 2009 | $56,291 | | tax credit/rebate |
PFIZER INC | Tennessee | local | 2011 | $57,012 | | property tax abatement |
Hospira, Inc. | North Carolina | state | 2014 | $59,897 | | tax credit/rebate |
Pfizer Inc. | Maryland | state | 2005 | $60,097 | | tax credit/rebate |
Icagen, Inc. | North Carolina | state | 2015 | $60,444 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Maryland | state | 2012 | $60,651 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Maryland | state | 2014 | $60,651 | | tax credit/rebate |
Embrex, Inc. | North Carolina | state | 2015 | $61,459 | | tax credit/rebate |
PFIZER INC | Tennessee | local | 2010 | $62,485 | | property tax abatement |
Embrex, Inc. | North Carolina | state | 2003 | $65,000 | | grant |
Pfizer Holdings Americas Corporation | North Carolina | state | 2016 | $66,776 | | tax credit/rebate |
PFIZER INC | Tennessee | local | 2008 | $67,264 | | property tax abatement |
Hospira, Inc. | Kansas | state | 2006 | $68,770 | | training reimbursement |
PFIZER INC | Tennessee | local | 2009 | $69,750 | | property tax abatement |
Pfizer, Inc. | North Carolina | state | 2021 | $72,208 | | tax credit/rebate |
Pharmacia Corporation | Maryland | state | 2008 | $74,621 | | tax credit/rebate |
Pfizer, Inc. & Subsidiaries | Maryland | state | 2016 | $79,533 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2011 | $85,000 | | tax credit/rebate |
PFIZER INC | Tennessee | local | 2009 | $86,991 | | property tax abatement |
Pfizer Inc. & Subsidiaries | Maryland | state | 2018 | $92,193 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Illinois | state | 2004 | $100,000 | | tax credit/rebate |
BioRexis Pharmaceutical Corporation | Pennsylvania | state | | $100,000 | | grant |
Hospira, Inc. | Kansas | state | 2007 | $103,000 | | grant |
Innopharma Inc. | New Jersey | state | 2009 | $119,831 | | grant |
Pfizer Corporation | Maryland | state | 2007 | $123,426 | | tax credit/rebate |
Wyeth Holdings LLC | North Carolina | state | 2019 | $125,000 | | grant |
Pfizer, Inc. | Maryland | state | 2008 | $131,514 | | tax credit/rebate |
Wyeth Holdings Corporation | North Carolina | state | 2014 | $143,193 | | tax credit/rebate |
Pharmacia Corporation | North Carolina | state | 2013 | $145,378 | | tax credit/rebate |
Pfizer (project 2) | North Carolina | state | 2022 | $153,219 | | training reimbursement |
Wyeth | Pennsylvania | state | 2009 | $154,958 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Maryland | state | 2017 | $183,559 | | tax credit/rebate |
Pfizer Holdings Americas Corporation | North Carolina | state | 2015 | $187,566 | | tax credit/rebate |
Wyeth Holdings Corporation | North Carolina | state | 2011 | $189,498 | | tax credit/rebate |
Hospira, Inc. | Kansas | state | 2007 | $190,000 | | training reimbursement |
Pfizer, Inc. | North Carolina | state | 2010 | $195,448 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Illinois | state | 2005 | $196,965 | | grant |
Hospira, Inc. and Subsidiaries | Illinois | state | 2005 | $196,965 | | grant |
Hospira, Inc. and Subsidiaries | Illinois | state | 2005 | $200,000 | | grant |
Hospira, Inc. and Subsidiaries | Illinois | state | 2005 | $200,000 | | grant |
Hospira, Inc. | North Carolina | state | 2008 | $200,000 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2014 | $218,428 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2020 | $218,433 | | tax credit/rebate |
Wyeth Holdings Corporation | North Carolina | state | 2012 | $218,644 | | tax credit/rebate |
PFIZER INC | New York | local | 2011 | $228,375 | | property tax abatement |
PFIZER INC | New York | local | 2012 | $228,420 | | property tax abatement |
Hospira, Inc. | North Carolina | state | 2013 | $231,735 | | tax credit/rebate |
Pfizer Holdings Americas Corporation | North Carolina | state | 2015 | $236,159 | | tax credit/rebate |
Pfizer, Inc. | North Carolina | state | 2020 | $236,439 | | tax credit/rebate |
Pfizer, Inc. | Pennsylvania | state | 2016 | $237,427 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2015 | $240,137 | | tax credit/rebate |
BioRexis | Pennsylvania | state | | $250,000 | | training reimbursement |
Hospira, Inc. | North Carolina | state | 2011 | $252,000 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2008 | $254,292 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2013 | $261,281 | | tax credit/rebate |
Wyeth Holdings Corporation | North Carolina | state | 2013 | $272,967 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2016 | $277,903 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2019 | $280,119 | | tax credit/rebate |
WYETH HOLDINGS CORPORATION | New York | local | 2009 | $280,900 | | tax credit/rebate; property tax abatement |
Pfizer, Inc. | North Carolina | state | 2017 | $305,389 | | tax credit/rebate |
PFIZER, INC. | Missouri | state | 2000 | $315,055 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2011 | $344,981 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2012 | $357,613 | | tax credit/rebate; property tax abatement |
Doral/Pfizer | New York | local | 2011 | $360,540 | | tax credit/rebate; property tax abatement |
Wyeth Holdings Corporation | North Carolina | state | 2010 | $373,801 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2015 | $402,469 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2016 | $402,469 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Illinois | state | 2007 | $404,000 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2016 | $415,010 | | tax credit/rebate |
Pfizer Inc., and Subsidiaries | Maryland | state | 2015 | $427,891 | | tax credit/rebate |
HOSPIRA, INC. | California | state | 2006 | $439,595 | | training reimbursement |
Doral/Pfizer | New York | local | 2008 | $462,392 | | tax credit/rebate; property tax abatement |
Hospira, Inc. | North Carolina | state | 2013 | $483,750 | | grant |
Pfizer, Inc. | North Carolina | state | 2018 | $495,412 | | tax credit/rebate |
Wyeth-Ayerst Pharmaceuticals | Pennsylvania | state | | $500,000 | | grant |
Wyeth Pharmaceuticals, Inc. | Pennsylvania | state | | $500,000 | | grant |
Wyeth-Lederle (#2) | North Carolina | state | 2004 | $500,000 | | grant |
Pfizer, Inc. | New York | state | 2005 | $500,000 | | enterprise zone |
Pfizer, Inc. | North Carolina | state | 2011 | $501,793 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2021 | $512,192 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2013 | $516,004 | | tax credit/rebate; property tax abatement |
HOSPIRA, INC. | California | state | 2009 | $536,590 | | training reimbursement |
Hospira, Inc. | North Carolina | state | 2008 | $537,281 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2010 | $596,605 | | tax credit/rebate; property tax abatement |
Doral/Pfizer | New York | local | 2014 | $607,052 | | tax credit/rebate |
Pfizer, Inc. | North Carolina | state | 2012 | $607,213 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2003 | $613,020 | | tax credit/rebate; property tax abatement |
Hospira, Inc. | North Carolina | state | 2015 | $623,585 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2022 | $632,089 | | tax credit/rebate |